The AWARD 7 study shows that adding on weekly doses of a GLP1-RA (dulaglutide) to the administration of insulin glargine yielded results similar in metabolic control, but superior in renal benefits in patients with DKD using pre-prandial rapid insulin BB [18]. This evidence concerns the gene GCG and diabetic kidney disease.